Product NDC: | 63304-693 |
Proprietary Name: | Clindamycin hydrochloride |
Non Proprietary Name: | Clindamycin hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; Clindamycin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-693 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065061 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010323 |
Package NDC: | 63304-693-77 |
Package Description: | 100 CAPSULE in 1 CARTON (63304-693-77) |
NDC Code | 63304-693-77 |
Proprietary Name | Clindamycin hydrochloride |
Package Description | 100 CAPSULE in 1 CARTON (63304-693-77) |
Product NDC | 63304-693 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20010323 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |